Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Oliviero James F III Create: Alert

All | News | Filings
Date FiledTypeDescription
04/04/2023 4 Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.
Txns: Granted 250,000 shares @ $0
03/03/2023 4 Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.
Txns: Sold 5,548 shares @ $4.65, valued at $25.8k
Granted 15,000 shares @ $0
Sold 5,483 shares @ $5, valued at $27.4k
02/03/2023 4 Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.
Txns: Sold 10,261 shares @ $4.77, valued at $48.9k
01/12/2023 4 Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.
Txns: Sold 3,817 shares @ $6.749, valued at $25.8k
01/12/2023 5 Oliviero James F III (CEO, President and Director) has filed a Form 5 on Checkpoint Therapeutics, Inc.
07/01/2022 4 Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.
Txns: Sold 228,000 shares @ $1.09, valued at $248.5k
Sold 21,000 shares @ $1.09, valued at $22.9k
Sold 12,000 shares @ $1.09, valued at $13.1k
Sold 15,000 shares @ $1.11, valued at $16.7k
04/22/2022 4 Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.
Txns: Paid exercise price by delivering 302,777 shares @ $3.11, valued at $941.6k
Paid exercise price by delivering 53,024 shares @ $2.77, valued at $146.9k
Paid exercise price by delivering 143,136 shares @ $2.19, valued at $313.5k
Paid exercise price by delivering 31,972 shares @ $2.46, valued at $78.7k
Paid exercise price by delivering 117,657 shares @ $1.85, valued at $217.7k
Sold 86,353 shares @ $1.79, valued at $154.6k
Sold 14,030 shares @ $1.77, valued at $24.8k
Sold 21,258 shares @ $1.51, valued at $32.1k
04/05/2022 4 Oliviero James F III (Director) has filed a Form 4 on Nuvectis Pharma, Inc.
Txns: Granted 15,000 options to buy @ $7.02, valued at $105.3k
02/08/2022 3 Oliviero James F III (Director) has filed a Form 3 on Nuvectis Pharma, Inc.
02/02/2022 4 Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.
Txns: Granted 455,000 shares @ $0
02/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/25/2019 4 Oliviero James F III (CEO, President and Director) has filed a Form 4 on Checkpoint Therapeutics, Inc.
Txns: Granted 485,000 shares @ $0
02/01/2018 4 Oliviero James F III (CEO and President) has filed a Form 4 on Checkpoint Therapeutics, Inc.
Txns: Granted 325,000 shares @ $0
12/19/2016 4 Oliviero James F III (CEO and President) has filed a Form 4 on Checkpoint Therapeutics, Inc.
10/04/2016 3 Oliviero James F III (CEO and President) has filed a Form 3 on Checkpoint Therapeutics, Inc.
07/08/2015 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Sold 1,943 shares @ $9.61, valued at $18.7k
05/12/2015 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Exercised 18,333 options to buy @ $2.53, valued at $46.4k
Exercised 23,278 options to buy @ $2.78, valued at $64.7k
04/08/2015 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Sold 1,878 shares @ $11.68, valued at $21.9k
01/06/2015 4 Form 4 - Statement of changes in beneficial ownership of securities
12/12/2014 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Exercised 25,000 shares @ $11.22, valued at $280.5k
Sold 25,000 shares @ $15.69, valued at $392.3k
10/07/2014 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Sold 2,694 shares @ $16.14, valued at $43.5k
09/10/2014 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Sold 144,237 shares @ $15.88, valued at $2.3M
07/09/2014 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Sold 2,054 shares @ $15.75, valued at $32.4k
04/07/2014 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Sold 2,087 shares @ $16.46, valued at $34.4k
03/21/2014 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Exercised 36,667 shares @ $2.53, valued at $92.8k
Exercised 18,622 shares @ $2.78, valued at $51.8k
Exercised 48,750 shares @ $4.58, valued at $223.3k
Sold 154,039 shares @ $15.23, valued at $2.3M
Sold 125,000 shares @ $15.04, valued at $1.9M
Sold 13,444 shares @ $15.11, valued at $203.1k
01/06/2014 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Granted 22,741 shares @ $0
Sold 6,309 shares @ $12.57, valued at $79.3k
Granted 53,062 options to buy @ $12.63, valued at $670.2k
12/31/2013 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Sold 30,000 shares @ $12.68, valued at $380.4k
Sold 49,500 shares @ $12.62, valued at $624.7k
Exercised 30,000 shares @ $4.59, valued at $137.7k
Sold 30,000 shares @ $12.64, valued at $379.2k
10/07/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
01/04/2013 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Granted 33,520 shares @ $0
Sold 10,859 shares @ $2.74, valued at $29.8k
Granted 55,866 options to buy @ $2.78, valued at $155.3k
10/05/2012 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Sold 4,973 shares @ $2.72, valued at $13.5k
07/06/2012 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Sold 4,559 shares @ $1.99, valued at $9.1k
05/22/2012 4 Oliviero James F III (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC
Txns: Granted 400,000 shares @ $0
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy